Korean J Anesthesiol Search

CLOSE


Korean J Anesthesiol > Epub ahead of print
DOI: https://doi.org/10.4097/kja.25413    [Epub ahead of print]
Published online September 23, 2025.
Evolving perspectives on blood transfusion in obstetric hemorrhage: a narrative review
Yoon Ji Choi1  , Sang Hun Kim2,3 
1Department of Anesthesiology and Pain Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea
2Department of Anesthesiology and Pain Medicine, Chosun University Hospital, Gwangju, Korea
3Department of Anesthesiology and Pain Medicine, College of Medicine, Chosun University, Gwangju, Korea
Corresponding author:  Sang Hun Kim, Tel: +82-62-220-3578, Fax: +82-62-223-2333, 
Email: ksh3223@chosun.ac.kr
Received: 18 May 2025   • Revised: 27 August 2025   • Accepted: 29 August 2025
Abstract
Globally, postpartum hemorrhage is still among the most significant factors in preventable maternal morbidity and mortality. Although early recognition and intervention have improved with advances in obstetric care, transfusion practices are often based on fixed thresholds that may not accurately reflect the unique physiological changes that occur during pregnancy or in the clinical context of acute bleeding. In this narrative review, we propose a phase-specific, patient-centered transfusion strategy for the preoperative, intraoperative, and postpartum periods. Key components of this strategy include proactive anemia correction during pregnancy, timely administration of uterotonic agents, early implementation of antifibrinolytic therapy, such as tranexamic acid within 3 h of bleeding onset, and appropriate activation of massive transfusion protocols when severe hemorrhage is ongoing. Clinical decision-making should be based on continuous assessment of maternal status, rather than on static hemoglobin values. Point-of-care coagulation monitoring, including thromboelastography and rotational thromboelastometry, can allow rapid identification of coagulopathy and support goal-directed transfusion. For high-risk populations, such as those with placenta accreta spectrum or those who decline allogeneic transfusion, strategies can include intraoperative cell salvage and non-blood interventions. Balanced transfusion approaches, using equal ratios of red blood cells, plasma, and platelets, at an early stage have demonstrated improved outcomes. Standardized protocols, multidisciplinary collaboration, and the integration of emerging technologies may further improve safety, minimize unnecessary transfusions, and promote consistency of care in the management of obstetric hemorrhage.
Key Words: Anemia; Antifibrinolytic agents; Blood component transfusion; Hematinics; Operative blood salvage; Oxytocics; Point-of-care systems; Postpartum hemorrhage; Thromboelastography


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
101-3503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-792-5128    Fax: +82-2-792-4089    E-mail: journal@anesthesia.or.kr                
Business Name: Korean Society of Anesthesiologists
Business Registration: 106-82-07194
Representative: Young-Tae Jeon

Copyright © 2025 by Korean Society of Anesthesiologists.

Developed in M2PI

Close layer
prev next